Erratum: A multidisciplinary "think tank": The top 10 clinical trial opportunities in transfusion medicine from the National Heart, Lung, and Blood Institute-sponsored 2009 state-of-the-science symposium (Transfusion (2011) 51 (828-841) DOI: 10.1111/j.1537-2995.2010.02898.x);A multidisciplinary "think tank": The top 10 clinical trial opportunities in transfusion medicine from the National Heart, Lung, and Blood Institute-sponsored 2009 state-of-the-science symposium

Transfusion

Volumn 51, Issue 4, 2011, Pages 828-841

  Josephson, Cassandra D ^a,b,c,d,e   Glynn, Simone A ^a,b,c,d   Kleinman, Steve H ^a,b,c,d   Blajchman, Morris A ^a,b,c,d  

^a EMORY UNIVERSITY   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

^e CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOIMMUNIZATION; ANESTHESIST; APHERESIS; ARTICLE; BLEEDING; BLOOD CONSERVATION; BLOOD DONOR; BLOOD TRANSFUSION; CLINICAL PRACTICE; CORONARY ARTERY DISEASE; CRITICALLY ILL PATIENT; CRYOPRECIPITATE; ERYTHROCYTE TRANSFUSION; EXTREMELY LOW BIRTH WEIGHT; HEART MUSCLE ISCHEMIA; HEART SURGERY; HUMAN; MEDICAL SOCIETY; OUTCOME ASSESSMENT; PATIENT SAFETY; PEDIATRICS; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PHYSICIAN; PLASMA TRANSFUSION; RESUSCITATION; SURGEON; SURVIVAL RATE; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

EID: 78649463736     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03804.x     Document Type: Erratum

References (35)

1. Sullivan MT, Cotton R, Read EJ, Wallace EL,. Blood collection and transfusion in the United States in 2001. Transfusion 2007; 47: 385-94.
2. Slichter SJ, Kaufman R, Assmann SF, McCullough J, Triuluzi D, Strauss RG, Gernsheimer TB, Ness PM, Brecher ME, Josephson CD, Konkle B, Woodson RD, Ortel T, Hillyer CD, Skerrett DL, McCrae K, Sloan SR, Uhl L, George JN, Buchannan G, Manno C, McFarland JG, Hess JR, Leissinger C, Granger S,. Effects of platelet dose on transfusion outcomes (The PLADO Trial, A Transfusion Medicine/Hemostasis Clinical Trials Network Study). N Engl J Med 2010; 362: 600-13.
3. Andrew M, Vegh P, Caco C, Kirpalani H, Jefferies A, Ohlsson A, Watts J, Saigal S, Milner R, Wang E,. A randomized, controlled trial of platelet transfusions in thrombocytopenic premature infants. J Pediatr 1993; 123: 286-91.
4. Murray NA, Howarth LJ, McCloy MP, Letsky EA, Roberts IA,. Platelet transfusion in the management of severe thrombocytopenia in neonatal intensive care unit patients. Transfus Med 2002; 12: 35-41. (Pubitemid 34184944)
5. Josephson CD, Su LL, Christensen RD, Hillyer CD, Castillejo MI, Emory MR, Lin Y, Hume H, Easley K, Poterjoy B, Sola-Visner M,. Platelet transfusion practices among neonatologists in the United States and Canada: results of a survey. Pediatrics 2009; 123: 278-85.
6. Stanworth SJ, Clarke P, Watts T, Ballard S, Choo L, Morris T, Murphy MF, Roberts I, Platelets and Neonatal Transfusion Study Group. Prospective, observational study of outcomes in neonates with severe thrombocytopenia. Pediatrics 2009; 124: e826-834.
7. Blajchman MA, Slichter SJ, Heddle NM, Murphy MF,. New strategies for the optimal use of platelet transfusions. Hematology Am Soc Hematol Educ Program 2008; 198-204.
8. Stanworth SJ, Dyer C, Choo L, Bakrania L, Copplestone A, Llewelyn C, Norfolk D, Powter G, Littlewood T, Wood EM, Murphy MF, TOPPS Study Group. Do all patients with hematologic malignancies and severe thrombocytopenia need prophylactic platelet transfusions? Background, rationale, and design of a clinical trial (Trial of Platelet Prophylaxis) to assess the effectiveness of prophylactic platelet transfusions. Transfus Med Rev 2010; 24: 163-71.
9. Wandt H, Schaefer-Eckart K, Pilz B, Thalheimer M, Ho AD, Schaich M, Kaufmann M, Aulitzky WE, Haenel M, Herbst R, Doelken G, Klenner AF, Freund M, Junghanss C, Ehninger G,. Experience with a therapeutic platelet transfusion strategy in acute myeloid leukemia: preliminary results of a randomized multicenter study after enrollment of 175 patients. Blood 2009; 113 (Suppl): 289a-90a. [abstract].
10. Kirpalani H, Whyte RK, Andersen C, Asztalos EV, Heddle N, Blajchman MA, Peliowski A, Rios A, LaCorte M, Connelly R, Barrington K, Roberts RS,. The premature infants in need of transfusion (PINT) study: a randomized, controlled trial of a restrictive (low) versus liberal (high) transfusion threshold for extremely low birth weight infants. J Pediatr 2006; 149: 301-7.
11. Whyte RK, Kirpalani H, Asztalos EV, Andersen C, Blajchman M, Heddle N, LaCorte M, Robertson CM, Clarke MC, Vincer MJ, Doyle LW, Roberts RS, PINTOS Study Group. Neurodevelopmental outcome of extremely low birth weight infants randomly assigned to restrictive or liberal hemoglobin thresholds for blood transfusion. Pediatrics 2009; 123: 207-13.
12. Bell EF, Strauss RG, Widness JA, Mahoney LT, Mock DM, Seward VJ, Cress GA, Johnson KJ, Kromer IJ, Zimmerman MB,. Randomized trial of liberal versus restrictive guidelines for red blood cell transfusion in preterm infants. Pediatrics 2005; 115: 1685-91. (Pubitemid 43843180)
13. Lacroix J, Hébert PC, Hutchison JS, Hume HA, Tucci M, Ducruet T, Gauvin F, Collet JP, Toledano BJ, Robillard P, Joffe A, Biarent D, Meert K, Peters MJ, TRIPICU Investigators, Canadian Critical Care Trials Group, Pediatric Acute Lung Injury and Sepsis Investigators Network. Transfusion strategies for patients in pediatric intensive care units. N Eng J Med 2007; 356: 1609-19. (Pubitemid 46631670)
14. Surgenor DM, Churchill WH, Wallace EL, Rizzo RJ, McGurk S, Goodnough LT, Kao KJ, Koerner TA, Olson JD, Woodson RD,. The specific hospital significantly affects red cell and component transfusion practice in coronary artery bypass graft surgery: a study of five hospitals. Transfusion 1998; 38: 122-34. (Pubitemid 28145078)
15. Johnson RG, Thurer RL, Kruskall MS, Sirois C, Gervino EV, Critchlow J, Weintraub RM,. Comparison of two transfusion strategies after elective operations for myocardial revascularization. J Thorac Cardiovasc Surg 1992; 104: 307-14.
16. Koch CG, Li L, Duncan AI, Mihaljevic T, Loop FD, Starr NJ, Blackstone EH,. Transfusion in coronary artery bypass grafting is associated with reduced long-term survival. Ann Thorac Surg 2006; 81: 1650-7. (Pubitemid 350030027)
17. Bell ML, Grunwald GK, Baltz JH, McDonald GO, Bell MR, Grover FL, Shroyer AL,. Does preoperative hemoglobin independently predict short-term outcomes after coronary artery bypass graft surgery. Ann Thorac Surg 2008; 86: 1415-23.
18. Alghamdi AA, Davis A, Brister S, Corey P, Logan A,. Development and validation of Transfusion Risk Understanding Scoring Tool (TRUST) to stratify cardiac surgery patients according to their blood transfusion needs. Transfusion 2006; 46: 1120-9. (Pubitemid 44139485)
19. Alexander KP, Chen AY, Wang TY, Rao SV, Newby LK, LaPointe NM, Ohman EM, Roe MT, Boden WE, Harrington RA, Peterson ED, CRUSADE Investigators. Transfusion practice and outcomes in non-ST-segment elevation acute coronary syndromes. Am Heart J 2008; 155: 1047-53.
20. Hébert PC, Yetisir E, Martin C, Blajchman MA, Wells G, Marshall J, Tweeddale M, Pagliarello G, Schweitzer I, Transfusion Requirements in Critical Care Investigators for the Canadian Critical Care Trials Group. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med 2001; 29: 227-34. (Pubitemid 32171763)
21. Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E,. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340: 409-17. (Pubitemid 29084771)
22. Borgman MA, Spinella PC, Perkins JG, Grathwohl KW, Repine T, Beekley AC, Sebesta J, Jenkins D, Wade CE, Holcomb JB,. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 2007; 63: 805-13. (Pubitemid 350287298)
23. Perkins JG, Cap AP, Spinella PC, Blackbourne LH, Grathwohl KW, Repine TB, Ketchum L, Waterman P, Lee RE, Beekley AC, Sebesta JA, Shorr AF, Wade CE, Holcomb JB,. An evaluation of the impact of apheresis platelets used in the setting of massively transfused trauma patients. J Trauma 2009; 66 (4 Suppl): S77-85.
24. Holcomb JB, Wade CE, Michalek JE, Chisholm GB, Zarzabal LA, Schreiber MA, Gonzalez EA, Pomper GJ, Perkins JG, Spinella PC, Williams KL, Park MS,. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg 2008; 248: 447-58.
25. Maegele M, Lefering R, Paffrath T, Tjardes T, Simanski C, Bouillon B, Working Group on Polytrauma of the German Society of Trauma Surgery (DGU). Red-blood-cell to plasma ratios transfused during massive transfusion are associated with mortality in severe multiple injury: a retrospective analysis from the Trauma Registry of the Deutsche Gesellschaft für Unfallchirurgie. Vox Sang 2008; 95: 112-9. (Pubitemid 351951900)
26. Dickert N, Sugarman J,. Ethical goals of community consultation in research. Am Journal Public Health 2005; 95: 1123-7. (Pubitemid 40880859)
27. Kleinman S, Dumont LJ, Tomasulo P, Bianco C, Katz L, Benjamin RJ, Gajic O, Brecher ME,. The impact of discontinuation of 7-day storage of apheresis platelets (PASSPORT) on recipient safety: an illustration of the need for proper risk assessment. Transfusion 2009; 49: 903-12.
28. Ruane PH, Edrich R, Gampp D, Keil SD, Leonard RL, Goodrich RP,. Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light. Transfusion 2004; 44: 877-85. (Pubitemid 38738418)
29. AuBuchon JP, Herschel L, Roger J, Taylor H, Whitley P, Li J, Edrich R, Goodrich RP,. Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction. Transfusion 2005; 45: 1335-41. (Pubitemid 41647801)
30. TRAP Study Group. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. N Engl J Med 1997; 337: 1861-9.
31. Slichter SJ, Davis K, Enright H, Braine H, Gernsheimer T, Kao KJ, Kickler T, Lee E, McFarland J, McCullough J, Rodey G, Schiffer CA, Woodson R,. Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood 2005; 105: 4106-14. (Pubitemid 40656162)
32. Hanson SR, Slichter SJ,. Platelet kinetics in patients with bone marrow hypoplasia: evidence for a fixed platelet requirement. Blood 1985; 66: 1105-9. (Pubitemid 16250275)
33. Asano H, Lee CY, Fox-Talbot K, Koh CM, Erdinc MM, Marschner S, Keil S, Goodrich RP, Baldwin WM,. Treatment with riboflavin and ultraviolet light prevents alloimmunization to platelet transfusions and cardiac transplants. Transplant 2007; 15: 1174-82. (Pubitemid 350125361)
34. McCullough J, Vesole DH, Benjamin RJ, Slichter SJ, Pineda A, Snyder E, Stadtmauer EA, Lopez-Plaza I, Coutre S, Strauss RG, Goodnough LT, Fridey JL, Raife T, Cable R, Murphy S, Howard F 4th, Davis K, Lin JS, Metzel P, Corash L, Koutsoukos A, Lin L, Buchholz DH, Conlan MG,. Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial. Blood 2004; 104: 1534-41. (Pubitemid 39166535)
35. Blajchman MA, Glynn SA, Josephson CD, Kleinman SH,. Clinical trial opportunities in transfusion medicine: proceedings of an NHLBI State-of-the-Science Symposium. Transf Med Rev. In press 2010.